(Q44796596)

English

Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age.

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Insulin autoantibodies are of less value compared with islet antibodies in the clinical diagnosis of autoimmune type 1 diabetes in children older than 3 yr of age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

type-1 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H Borg

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C Marcus

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

S Sjöblad

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

P Fernlund

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

G Sundkvist

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pediatric Diabetes

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

149-154

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Onset age-dependent variations of three islet specific autoantibodies in Japanese IDDM patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Type 2 diabetes mellitus in UK children--an emerging problem.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Islet cell antibody frequency differs from that of glutamic acid decarboxylase antibodies/IA2 antibodies after diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

An 8-year follow-up of anti-insulin antibodies in diabetic children: relation to insulin autoantibodies, HLA type, beta-cell function, clinical course and type of insulin therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

21 January 2018

Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5448.2002.30305.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-5448.2002.30305.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44796596&oldid=1452211667"